SPECT and MRI analysis in Alzheimer's disease: Relation to apolipoprotein E ε4 allele

Journal of Neurology Neurosurgery and Psychiatry

Volumn 60, Issue 6, 1996, Pages 644-649

  Lehtovirta, M ^a   Soininen, H ^a   Laakso, M P ^a   Partanen, K ^a   Helisalmi, S ^b   Mannermaa, A ^b   Ryynanen M ^b   Kuikka, J ^a   Hartikainen, P ^a   Riekkinen Sr , P J ^a  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Alzheimer's disease; Apolipoprotein E; Hippocampus, magnetic resonance imaging; SPECT; Volumetry

Indexed keywords

AMYLOID; APOLIPOPROTEIN E4; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; RESTRICTION ENDONUCLEASE;

ADULT; AGED; ALZHEIMER DISEASE; AMYGDALOID NUCLEUS; ARTICLE; BRAIN ATROPHY; BRAIN BLOOD FLOW; CEREBELLUM; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FRONTAL LOBE; GENETIC POLYMORPHISM; GENOTYPE; HIPPOCAMPUS; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROFIBRILLARY TANGLE; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK FACTOR; SENILE PLAQUE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYNAPTOGENESIS; TEMPORAL LOBE;

AGE OF ONSET; AGED; ALLELES; ALZHEIMER DISEASE; AMYGDALA; APOLIPOPROTEINS E; CEREBELLUM; FEMALE; FRONTAL LOBE; GENE EXPRESSION; GENOTYPE; HIPPOCAMPUS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; PARIETAL LOBE; REGIONAL BLOOD FLOW; TEMPORAL LOBE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0029886171     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.60.6.644     Document Type: Article

References (54)

1. Jack CR, Petersen RC, O'Brien PC, Tangalos EG. MR-based hippocampal volumetry in the diagnosis of Alzheimer's disease. Neurology 1992;42:183-8.
2. Kesslak JP, Nalcioglu O, Cotman CW. Quantification of magnetic resonance scans for hippocampal and parahippocampal atrophy in Alzheimer's disease. Neurology 1991;41:51-4.
3. Killiany RJ, Moss MB, Albert MS, Sandor T, Tieman J, Jolesz F. Temporal lobe regions on magnetic resonance imaging identify patients with early Alzheimer's disease. Arch Neurol 1993;50:949-54.
4. Seab JB, Jagust WJ, Wong STS, Roos MS, Reed BR, Budinger TF. Quantitative NMR measurements of hippocampal atrophy in Alzheimer's disease. Magn Reson Med 1988;8:200-8.
5. Cuénod CA, Denys A, Michot J-L, et al. Amygdala atrophy in Alzheimer's disease. An in vivo magnetic resonance imaging study. Arch Neurol 1993;50:941-5.
6. Scott SA, DeKosky ST, Scheff SW. Volumetric atrophy of the amygdala in Alzheimer's disease: Quantitative serial reconstruction. Neurology 1991;41:351-6.
7. Burns A, Philpot M, Costa D, Ell P, Levy R. The investigation of Alzheimer's disease with single photon emission tomography. J Neurol Neurosurg Psychiatry 1989;52: 248-53.
8. Frackowiak R, Pozzilli C, Legg N, Boulay G, Marshall J, Jones T. Regional cerebral oxygen supply and utilisation in dementia. Brain 1981;104:753-78.
9. Gemmell H, Sharp O, Besson J. Differential diagnosis in dementia using the cerebral blood flow agent 99m TcHMPAO: a SPECT study. J Comput Assis Tomogr 1987;11:398-402.
10. Habert M, Spampinato U, Mas J, et al. A comparative technetium 99m hexametylpropylene amine oxime SPET study in different types of dementia. Eur J Nucl Med 1991;18:3-11.
11. Najlerahim A, Bowen D. Biochemical measurements in Alzheimer's disease reveal a necessity for improved neuroimaging tecniques to study metabolism. Biochem J 1988;251:305-8.
12. Kuusisto J, Koivisto K, Mykkänen L, et al. Association of apolipoprotein E phenotypes with late-onset Alzheimer's disease: a population-based study. Br Med J 1994;309: 636-8.
13. Lehtovirta M, Helisalmi S, Mannermaa A, et al. Apolipoprotein E polymorphism and Alzheimer's disease in Eastern Finland. Neurosci Lett 1995;185:13-15.
14. Mayeux R, Stern Y, Ottman R, et al. The apolipoprotein 4 allele in patients with Alzheimer's disease. Ann Neurol 1993;34:752-4.
15. Poirier J, Davignon J, Bouthillier D, Kogan S, Bertrand P, Gauthier S. Apolipoprotein polymorphism and Alzheimer's disease. Lancet 1993;342:697-9.
16. Saunders AM, Strittmatter WJ, Schmechel D, et al. Association of apolipoprotein E allele 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993;43:1467-72.
17. Strittmatter WJ, Saunders AM, Schmechel D, et al. Apolipoprotein E: High-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer's disease. Proc Natl Acad Sci USA 1993; 90:1977-81.
18. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993; 261:921-3.
19. Namba Y, Tomonaga M, Kawasaki H, Otomo E, Ikeda K. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jacob disease. Brain Res 1991;541:163-6.
20. Wisniewski T, Frangione B. Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci Lett 1992;135:235-8.
21. Strittmatter WJ, Weisgraber KH, Huang DY, et al. Binding of human apolipoprotein E to synthetic amyloid peptide: isoform-specific effects and implications for late-onset Alzheimer's disease. Proc Natl Acad Sci USA 1993;90: 8098-102.
22. Strittmatter WJ, Weisgraber KH, Goedert M, et al. Hypothesis: microtubule instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein E genotype. Exp Neurol 1994; 125:163-11.
23. Rebeck GW, Reiter JS, Strickland DK, Hyman BT. Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron 1993;11: 575-80.
24. Schmechel DE, Saunders AM, Strittmatter WJ, et al. Increased amyloid-peptide deposition as a consequence of apolipoprotein E genotype in late-onset Alzheimer's disease. Proc Natl Acad Sci USA 1993;90:9649-53.
25. Poirier J. Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease. TINS 1994;17:525-30.
26. Soininen H, Kosunen O, Helisalmi S, et al. A severe loss of choline acetyltransferase in the frontal cortex of Alzheimer patients carrying apolipoprotein 4 allele. Neurosci Lett 1995;187:79-82.
27. Poirier J, Hess M, May P, Finch CE. Apolipoprotein E-and GFAP-RNA in hippocampus during reactive synaptogenesis and terminal proliferation. Mol Brain Res 1991;11:97-106.
28. Lehtovirta M, Laakso M, Soininen H, et al. Volumes of hippocampus, amygdala, and frontal lobe in Alzheimer patients with different Apolipoprotein E genotypes. Neuroscience 1995;67:65-72.
29. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease. Report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-44.
30. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state": a practical method for grading the cognitive state of patients for the clinician. J Psychiatry Res 1975;12: 189-98.
31. Reisberg B, Schneck MK, Ferris SH. The brief cognitive rating scale (BCRS): findings in primary degenerative dementia (PDD). Psychopharmacol Bull 1983;19:734-9.
32. Webster DD. Clinical analysis of the disability on Parkinson's disease. Mod Treat 1968;5:257-62.
33. Hamilton M. A rating scale for depresssion. J Neurol Neurosurg Psychiatry 1960;23:56-62.
34. Rosen WG, Terry RD, Fuld PA, et al. Pathological verification of ischemic score in differentiation of dementias. Ann Neurol 1980;7:486-8.
35. Soininen H, Partanen K, Pitkänen A, et al. Volumetric MRI analysis of the amygdala and the hippocampus in subjects with age-associated memory impairment: correlation to visual and verbal memory. Neurology 1994; 44:1660-8.
36. DeArmond SJ, Fusco MM, Dewey MM. Structure of the human brain. A photographic atlas. 3rd ed. New York: Oxford University Press, 1989.
37. Duvernoy HM. The human hippocampus - an atlas of applied anatomy. Munich: JF Bergmann Verlag, 1988.
38. Watson C, Andermann F, Gloor P, et al Anatomical basis of amygdaloid and hippocampal volume measurement by magnetic resonance imaging. Neurology 1992;42: 1743-50.
39. Kuikka J, Tenhunen-Eskelinen M, Jurvelin J, Kiiliäinen H. Physical performance of the Siemens MultiSPECT 3 gamma camera. Nucl Med Com 1993;14:490-7.
40. Hixon JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 1990;31:545-8.
41. Tsukamoto K, Watanabe T, Matsushima T, et al. Determination by PCR-RFLP of apoE genotype in a Japanese population. J Lab Clin Med 1993;121:598-602.
42. Hyman BT, Van Hoesen GW, Damasio AR, Barnes CL. Alzheimer's disease: cell-specific pathology isolates the hippocampal formation. Science 1984;225:1168-70.
43. Bliss TVP, Collingridge GL. A synaptic model of memory: long-term potentiation in the hippocampus. Nature 1993;361:31-9.
44. Helkala E-L, Laulumaa V, Soininen H, Riekkinen PJ. Recall and recognition on memory in patients with Alzheimer's and Parkinson's diseases. Ann Neurol 1988;24:214-7.
45. Wechsler D. A standardised memory scale for clinical use. J Psychol 1945;19:87-95
46. Lehtovirta M, Soininen H, Helisalmi S, et al. Clinical and neuropsychological characteristics in familial and sporadic Alzheimer's disease: relation to apolipoprotein E polymorphism. Neurology 1996;46:413-9.
47. Jackson GD, Connelly A, Duncan DM, Grünewald RA, Gadian DG. Detection of hippocampal pathology in intractable partial epilepsy: Increased sensitivity with quantitative magnetic resonance T2 relaxometry. Neurology 1993;43:1793-9.
48. Kirsch SJ, Jacobs RW, Butcher LL, Beatry J. Prolongation of magnetic resonance T2 time in hippocampus of human patients marks the presence and severity of Alzheimer's disease. Neurosci Lett 1992;134:187-90.
49. Perani D, Di Piero V, Vallar G, et al. Technetium-99m HM-PAO-SPECT study of regional cerebral perfusion in early Alzheimer's disease. J Nucl Med 1988;29:1507-14.
50. Johnson K, Mueller S, Walshe T, English R, Holman B. Cerebral perfusion imaging in Alzheimer's disease. Arch Neurol 1987;44:165-8.
51. 123I]-IBZM in Alzheimer's disease and dementia of frontal type: preliminary results. Acta Neurol Scand 1994; 89:199-203.
52. O'Brien JT, Eagger S, Syed GMS, Sahakian BJ, Levy R. A study of regional cerebral blood flow and cognitive performance in Alzheimer's disease J Neurol Neurosurg Psychiatry 1992;55:1182-7.
53. Sato A, Sato Y. Regulation of regional cerebral blood flow by cholinergic fibers originating in the basal forebrain. Neurosci Res 1992;14:242-74.
54. McCormick DA. Cellular mechanisms of cholinergic control of neocortical and thalamic neuronal excitability. In: Steriade M, Biesold D, eds. Brain cholinergic systems. New York: University Press,1990:236-64.